- Home
- HOOD vs BSX Comparison
HOOD vs BSX Comparison
Compare HOOD & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOOD | BSX |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | 53000 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.2B | 137.8B |
| IPO Year | 2021 | 1992 |
Fundamental Metrics
Financial Performance| Metric | HOOD | BSX |
|---|---|---|
| Price | $116.70 | $94.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 17 |
| Target Price | $119.48 | ★ $126.24 |
| AVG Volume (30 Days) | ★ 27.9M | 10.3M |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 304.26 | 54.68 |
| EPS | ★ 2.39 | 1.87 |
| Revenue | $4,204,000,000.00 | ★ $19,349,000,000.00 |
| Revenue This Year | $54.86 | $21.05 |
| Revenue Next Year | $22.41 | $11.43 |
| P/E Ratio | $49.94 | ★ $49.71 |
| Revenue Growth | ★ 74.58 | 21.61 |
| 52 Week Low | $29.66 | $85.98 |
| 52 Week High | $153.86 | $109.50 |
Technical Indicators
Market Signals| Indicator | HOOD | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 40.61 |
| Support Level | $114.10 | $90.42 |
| Resistance Level | $139.75 | $93.89 |
| Average True Range (ATR) | 6.22 | 2.14 |
| MACD | -1.11 | -0.40 |
| Stochastic Oscillator | 9.55 | 31.24 |
Price Performance
Historical ComparisonAbout HOOD Robinhood Markets Inc.
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.